[Effect of noradrenaline and endogenous opioid peptide systems on the anxiogenic action of inverse benzodiazepine receptor agonist DMCM].
Yang
X M
XM
Lou
Z P
ZP
Zhou
J H
JH
D000818:Animals; D001007:Anxiety / Q000139:chemically induced / Q000517:prevention & control; D002243:Carbolines / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D004723:Endorphins / Q000494:pharmacology*; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D011963:Receptors, GABA-A / Q000187:drug effects; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology
D002243:Carbolines; D004723:Endorphins; D011963:Receptors, GABA-A; C034818:methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate; D005680:gamma-Aminobutyric Acid; D009638:Norepinephrine